Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_provenance.
- NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_assertion description "[In conclusion, our results indicate that a search for Gale-3 protein overexpression by IIC or ICC, but not by reverse transcription-polymerase chain reaction (RT-PCR), may yield an additional marker of malignant potential of thyroid nodular lesions, and may be a useful adjunct to the currently available diagnostic tools for the preoperative diagnosis of malignant thyroid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_provenance.
- NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_assertion evidence source_evidence_literature NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_provenance.
- NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_assertion SIO_000772 14558920 NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_provenance.
- NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_assertion wasDerivedFrom befree-20140225 NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_provenance.
- NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_assertion wasGeneratedBy ECO_0000203 NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP350496.RAT9ARi2299ayAyqc2xr0prt0zJczSEhiD_amwe2eHVtI130_provenance.